Notably, previous reports indicated that the PTX3 promoter tends to undergo extensive methylation and subsequent inactivation via epigenetic regulation in colon cancer cells [22, 40], shedding light on a possible explanation for our observations. Here, PTX3 is linked to malignant colon neoplasm.